PKM and colorectal carcinoma: Further studies have identified that FEZF1-AS1 enhances the stability of CRC cells by binding to PKM2 and increases the activity of PKM2, which leads to the enhancement of aerobic glycolysis of CRC cells and activates the STAT3 signaling pathway to facilitate the proliferation and metastasis of CRC cells [35].